<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Lim Swanson | Activity</title>
	<link>https://www.catswannabecats.com/members/searchbed6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/searchbed6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lim Swanson.</description>
	<lastBuildDate>Sat, 27 Jun 2026 07:28:19 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ba32299a13553565172028ac27162217</guid>
				<title>Lim Swanson posted an update: Application of 8-Br at the end of ischaemia protected the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24544/</link>
				<pubDate>Sun, 08 Jun 2025 12:56:16 -0400</pubDate>

									<content:encoded><![CDATA[<p>Application of 8-Br at the end of ischaemia protected the heart during reperfusion. 8-Br promoted binding of HKII to the mitochondria and reduced Ca2+-induced mitochondria swelling. Thus, 8-Br protects the heart when administered before regional ischaemia or at the beginning of reperfusion. This effect is associated with inhibition of MPTP via&hellip;<span class="activity-read-more" id="activity-read-more-24544"><a href="https://www.catswannabecats.com/activity/p/24544/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9fc392b6f45093df922feac9f7b1c5f1</guid>
				<title>Lim Swanson posted an update: NGS utilizing MinION technology for the detection of CMV [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21331/</link>
				<pubDate>Fri, 06 Jun 2025 13:27:44 -0400</pubDate>

									<content:encoded><![CDATA[<p>NGS utilizing MinION technology for the detection of CMV AVDR mutations identified additional minority variants in UL97 and UL54 as compared with Sanger sequencing. Through the application of a bioinformatics pipeline available online, our NGS process eliminates barriers associated with the use of the MinION and NGS in clinical&hellip;<span class="activity-read-more" id="activity-read-more-21331"><a href="https://www.catswannabecats.com/activity/p/21331/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">946272ab02682a8c9daa712e973d0909</guid>
				<title>Lim Swanson posted an update: This systematic review will provide evidence regarding the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18999/</link>
				<pubDate>Wed, 04 Jun 2025 12:09:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>This systematic review will provide evidence regarding the rate of H pylori reinfection and its risk factors after successful eradication. It can guide the management of patients with H pylori infection.</p>
<p>This systematic review will provide evidence regarding the rate of H pylori reinfection and its risk factors after successful eradication. It&hellip;<span class="activity-read-more" id="activity-read-more-18999"><a href="https://www.catswannabecats.com/activity/p/18999/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">29ddbd9649781370e2d936784fc6d6dd</guid>
				<title>Lim Swanson posted an update: Background Rate of corrective nasal surgery after [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/3536/</link>
				<pubDate>Sat, 31 May 2025 10:50:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>Background Rate of corrective nasal surgery after maxillomandibular advancement (MMA) for obstructive sleep apnea (OSA) has been reported to be 18.7% for functional and aesthetic indications. Objective Describe a comprehensive strategy to optimize nasal outcomes with MMA for OSA. Methods A retrospective review of patients undergoing MMA for OSA in&hellip;<span class="activity-read-more" id="activity-read-more-3536"><a href="https://www.catswannabecats.com/activity/p/3536/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e1f638fa1a07729c787753cb6f0640db</guid>
				<title>Lim Swanson became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/3386/</link>
				<pubDate>Sat, 31 May 2025 10:37:39 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>